Literature DB >> 8114953

Both beta 1- and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium.

A J Kaumann1, L Sanders.   

Abstract

The involvement of beta 1- and beta 2-adrenoceptors in catecholamine-evoked arrhythmias was investigated in isolated human right atrial appendages obtained from 22 patients chronically treated with beta blockers (usually beta 1-selective) and 9 patients not treated with beta blockers. A simple experimental model that assesses the incidence of arrhythmic contractions as a function of heart rate (pacing) is introduced. beta 1-adrenoceptors were activated by (-)-noradrenaline during beta 2-adrenoceptor blockade with 50 nmol/l ICI 118551. beta 2-adrenoceptors were activated by (-)-adrenaline during beta 1-adrenoceptor blockade with 300 nmol/l CGP 20712A. Both (-)-noradrenaline and (-)-adrenaline caused arrhythmic contractions whose incidence was greater at low than at high pacing rates. CGP 20712A (300 nmol/l) blocked the (-)-noradrenaline-evoked contractions in 1/1 atrial strip from 1/1 patient not treated with a beta blocker and 17/17 atrial strips from 15/15 patients chronically treated with beta blockers. ICI 118551 (50 nmol/l) blocked the (-)-adrenaline-evoked contractions in 3/4 atrial strips from 3/4 patients not treated with beta blockers and 17/20 atrial strips from 15/18 patients chronically treated with beta blockers. The incidence of arrhythmic contractions evoked by both (-)-noradrenaline and (-)-adrenaline was higher in chronically beta blocked patients than in non beta blocked patients. We conclude that both beta 1- and beta 2-adrenoceptors mediate atrial arrhythmias and that the generation of these arrhythmias is facilitated by chronic beta 1-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8114953     DOI: 10.1007/bf00173215

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

Review 1.  Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists.

Authors:  R W Tsien; B P Bean; P Hess; J B Lansman; B Nilius; M C Nowycky
Journal:  J Mol Cell Cardiol       Date:  1986-07       Impact factor: 5.000

2.  Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.

Authors:  M C Michel; A Pingsmann; J J Beckeringh; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium.

Authors:  J R Berlin; M B Cannell; W J Lederer
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

4.  In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment.

Authors:  J A Hall; M C Petch; M J Brown
Journal:  Circ Res       Date:  1991-10       Impact factor: 17.367

Review 5.  The beta-adrenergic blockade withdrawal phenomenon.

Authors:  B N Prichard; B Tomlinson; R J Walden; P Bhattacharjee
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

6.  Relations between beta-adrenoceptor occupancy and increases of contractile force and adenylate cyclase activity induced by catecholamines in human ventricular myocardium. Acute desensitization and comparison with feline ventricle.

Authors:  A J Kaumann; H Lemoine; U Schwederski-Menke; B Ehle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

7.  Arrhythmias after coronary bypass surgery.

Authors:  O J Ormerod; C G McGregor; D L Stone; C Wisbey; M C Petch
Journal:  Br Heart J       Date:  1984-06

8.  Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

9.  Contribution of beta 1- and beta 2-adrenoceptors of human atrium and ventricle to the effects of noradrenaline and adrenaline as assessed with (-)-atenolol.

Authors:  H Lemoine; H Schönell; A J Kaumann
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

10.  The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.

Authors:  E Gille; H Lemoine; B Ehle; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

View more
  16 in total

1.  Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.

Authors:  Peter Molenaar; Lu Chen; William A Parsonage
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Functional antagonism of β-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium.

Authors:  D C Boer; J W M Bassani; R A Bassani
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation.

Authors:  Torsten Christ; Nadiia Rozmaritsa; Andreas Engel; Emanuel Berk; Michael Knaut; Katharina Metzner; Manuel Canteras; Ursula Ravens; Alberto Kaumann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

4.  Cardiostimulant effects of urotensin-II in human heart in vitro.

Authors:  F D Russell; P Molenaar; D M O'Brien
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 5.  Pharmacological treatment of chronic heart failure.

Authors:  Rachele Adorisio; Leonardo De Luca; Joseph Rossi; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

6.  Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium.

Authors:  M D Lowe; E Rowland; M J Brown; A A Grace
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 7.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

8.  (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Surprises from a cardiac 5-HT₄TG mouse: spontaneous atrial arrhythmias by endogenous 5-HT of atrial origin? Different mechanism of arrhythmias through 5-HT₄ receptors and β-adrenoceptors?

Authors:  Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05       Impact factor: 3.000

10.  5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade.

Authors:  A J Kaumann; L Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.